As TLR4 is a common precipitator of inflammation in microbial infection, atherosclerosis, and vascular remodelling, they targeted a known regulator on inflammatory immune cells and VSMCs called RP105 (also known as CD180). Here, CD180 is linked to atherosclerosis.